Donald J. Tindall

Dr. Tindall was the first to demonstrate that androgen-independent prostate cancer cells still require the androgen receptor protein for tumor progression. This has led to a paradigm shift in the field of prostate cancer research and has pointed to the androgen receptor as a target for prognosis and novel therapeutics.